News
Antibody shows early promise in AML/MDS trial
MADRID—Interim results of a phase 1 study suggest flotetuzumab, a CD123 and CD3 bispecific antibody, may be a feasible treatment option for...
News
New toolkit can help nurses use genomics in patient care
The National Human Genome Research Institute (NHGRI) has created an online toolkit to help nurses integrate genomics into patient care. The...
News
Murine study provides new insight into hematopoiesis
Life-long hematopoiesis relies on hundreds more blood progenitors than previously reported, according to preclinical research published in Nature...
News
Trials of atezolizumab placed on partial hold
Roche has announced a partial clinical hold on 2 trials of the anti-PD-L1 antibody atezolizumab (Tecentriq). One is a phase 1b/2 study (...
News
EMA issues final opinion on FVIII products
The European Medicines Agency (EMA) has concluded there is “no clear and consistent evidence” of a difference in inhibitor development between the...
News
CHMP recommends approval of generic imatinib
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for...
News
CHMP advocates refusal of application for SM drug
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended refusal of the marketing authorization for...
News
Application for pegfilgrastim biosimilar withdrawn
Mylan S.A.S.
News
CHMP recommends approval of nilotinib for kids
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the authorized use for nilotinib (...
News
FDA approves drug to treat relapsed FL
The US Food and Drug Administration (FDA) has granted accelerated approval to copanlisib (Aliqopa), an intravenous PI3K inhibitor developed by...
News
Immune status linked to outcomes of CAR T-cell therapy
MAINZ/FRANKFURT, GERMANY—Outcomes of treatment with a third-generation chimeric antigen receptor (CAR) T-cell therapy are associated with a...
News
Survey reveals lack of specialized care for AYAs with cancer
MADRID—New research indicates there is a lack of specialized care in Europe for adolescents and young adults (AYAs) with cancer. In a survey of...
News
Report details progress, obstacles in cancer research and care
Deaths from cancer are on the decline in the US, but new cases of cancer are on the rise, according to the 7th annual American Association for...
News
Study raises questions about anemia in astronauts
Previous research has suggested that astronauts develop anemia during space flight, but a new study indicates this is not the case for astronauts...
News
FDA grants priority review for drug to treat APL
The US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) for arsenic trioxide (...